Ready for New Discoveries?

– Partner with a CRO you can count on

About Redoxis

Decision-enabling preclinical research in inflammation and immune-mediated diseases

Redoxis is a specialized preclinical CRO in Lund, Sweden, providing integrated in vitro, in vivo and high-resolution biology services. We design tailored studies to evaluate therapeutic efficacy, mechanism of action, PK/PD and translational biomarkers.

We focus on preclinical drug development and efficacy evaluation in models of inflammation and autoimmune disease. Rooted in academic research and driven by deep immunological expertise, we continuously advance and refine our portfolio of in vivo, ex vivo, and in vitro models to reflect the latest developments in translational immunology.

At Redoxis, every study is thoughtfully designed around your scientific question, therapeutic modality, and development phase. We combine mechanistic insight, rigorous execution, and transparent communication to generate robust, decision-enabling data.

Our scientists work closely with customers throughout the project—from study design and model selection to data interpretation and next-step recommendations. The result is scientifically robust, decision-enabling data that help development teams move forward with greater confidence.

More about us

In Vitro & Ex Vivo services

Services

Human and murine immune-cell assays, functional profiling, target validation, mechanism-of-action studies, cytokine analysis, flow cytometry, ELISpot and FluoroSpot. At Redoxis, we design scientifically tailored assays aligned with your biological question, therapeutic modality, and development phase. From pathway modulation and cytokine profiling to advanced immune cell phenotyping, our work is grounded in translational relevance and immunological expertise.

Our services

In Vivo Services

Services

Tailored efficacy and PK/PD studies using established models of rheumatoid arthritis, multiple sclerosis, lupus, inflammatory bowel disease, psoriasis, psoriatic arthritis and acute inflammation. At Redoxis, we specialize in well-characterized models of inflammation and autoimmune disease. Each study is thoughtfully designed around your mechanism of action, therapeutic modality, and development goals — ensuring biologically relevant and decision-enabling outcomes.

Our services

High-Resolution Biology

Services

Histology, immunohistochemistry, whole-slide imaging, quantitative image analysis and single-cell and spatial biology approaches. At Redoxis, we combine quantitative histopathology, advanced imaging platforms, and single-cell transcriptomic analysis to deliver multidimensional data with translational relevance. From tissue architecture and immune infiltration to pathway-specific cellular signatures, our approaches strengthen mechanistic understanding and support confident decision-making.

Our services

Customer Reviews

\"A professional company with personal touch.\"
Thomas Bäckström
BTB Pharma, Sweden
\"Redoxis provided us with state-of-the-art in vivo models, which we utilized to assess the efficacy and pharmacokinetics of our small molecule compounds. Their team delivered highly robust and reproducible data, which proved to be a critical component in advancing our early-stage drug development program.\"
Irene Knussel, Chief Scientific Officer
Rewind Therapeutics
\"It has been a real pleasure to collaborate with Redoxis, a CRO that we have the greatest confidence in. Swift planning of projects, starts of experiments with a minimum of delay, very professional staff and thus high standard studies and rapid and excellent reports are important elements in the development of this good relation.\"
Erik Walum, CEO
Glucox Biotech, Sweden